These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15701565)

  • 21. [Autoimmune epilepsy].
    Brodtkorb E
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):782. PubMed ID: 16568570
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunological disorders in epileptic patients are associated to the epileptogenic focus localization].
    Sánchez-Marín B; Grasa JM; Azúa-Romeo J
    Rev Neurol; 2005 Mar 1-15; 40(5):319; author reply 319-20. PubMed ID: 15782368
    [No Abstract]   [Full Text] [Related]  

  • 23. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP
    J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA.
    Ganor Y; Goldberg-Stern H; Lerman-Sagie T; Teichberg VI; Levite M
    Epilepsy Res; 2005 Jun; 65(1-2):11-22. PubMed ID: 15978777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunology of epilepsy].
    Sepić-Grahovac D; Sepcić J; Rukavina D
    Lijec Vjesn; 1989; 111(1-2):39-43. PubMed ID: 2661943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines.
    Ganor Y; Freilinger M; Dulac O; Levite M
    Autoimmunity; 2005 Mar; 38(2):139-50. PubMed ID: 16040334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can infections protect against autoimmunity?
    Gaisford W; Cooke A
    Curr Opin Rheumatol; 2009 Jul; 21(4):391-6. PubMed ID: 19412105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibody-mediated disorders of the central nervous system.
    Irani S; Lang B
    Autoimmunity; 2008 Feb; 41(1):55-65. PubMed ID: 18176865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
    Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M
    Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunological approach to the treatment of epilepsy.
    Cazzullo CL; Altamura AC; Smeraldi E
    Agressologie; 1976; 17(4):211-6. PubMed ID: 1008149
    [No Abstract]   [Full Text] [Related]  

  • 32. Epilepsy and the immune system.
    Aarli JA
    Arch Neurol; 2000 Dec; 57(12):1689-92. PubMed ID: 11115234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas.
    Sutherland AP; Mackay F; Mackay CR
    Pharmacol Ther; 2006 Dec; 112(3):774-86. PubMed ID: 16863659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interictal alterations of cytokines and leukocytes in patients with active epilepsy.
    Nowak M; Bauer S; Haag A; Cepok S; Todorova-Rudolph A; Tackenberg B; Norwood B; Oertel WH; Rosenow F; Hemmer B; Hamer HM
    Brain Behav Immun; 2011 Mar; 25(3):423-8. PubMed ID: 20977934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Poxviral immunomodulatory proteins as new therapeutics for immunocorrection].
    Nepomniashchikh TS; Shchelkunov SN
    Mol Biol (Mosk); 2008; 42(5):904-12. PubMed ID: 18988538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate and adaptive immunity in human epilepsies.
    Bauer J; Becker AJ; Elyaman W; Peltola J; Rüegg S; Titulaer MJ; Varley JA; Beghi E
    Epilepsia; 2017 Jul; 58 Suppl 3(Suppl Suppl 3):57-68. PubMed ID: 28675562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis.
    Levite M; Ganor Y
    Expert Rev Neurother; 2008 Jul; 8(7):1141-60. PubMed ID: 18590483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders.
    Gonzalez-Rey E; Delgado M
    Mol Cell Endocrinol; 2008 May; 286(1-2):135-40. PubMed ID: 17850953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes.
    Panayiotopoulos CP; Michael M; Sanders S; Valeta T; Koutroumanidis M
    Brain; 2008 Sep; 131(Pt 9):2264-86. PubMed ID: 18718967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.